Quantcast

Latest prostate cancer treatment Stories

2010-07-06 09:00:00

CORAL SPRINGS, Fla., July 6 /PRNewswire/ -- At the recent meeting of the American Urological Association in San Francisco, researchers presented studies regarding the decision making process men go through when considering proposed prostate cancer treatments. Dr. Vorstman, renowned Florida urologist, believes these studies would have more meaning if patients were presented with information about prostate cancer treatment options in a different fashion. Prostate cancer treatments fall into...

2010-03-23 11:39:00

ATLANTA, March 23 /PRNewswire/ -- Radiotherapy Centers of Georgia (RCOG), a division of RC Cancer Centers announced today that they have reached a new milestone and recently treated their 12,500th patient for prostate cancer with their ProstRcision® treatment therapy. The milestone means their treatment database is one of the most comprehensive in the nation. Available exclusively from RC Cancer Centers, ProstRcision® has the industry's highest...

2010-01-05 06:30:00

Urological Device Market Will Grow to More Than $5.4 Billion VANCOUVER, Jan. 5 /PRNewswire/ - According to a new global report series by iData Research, the leading authority in medical device, dental and pharmaceutical market research, the U.S. market for urological devices is estimated to more than double in value by 2016, reaching over $5.4 billion. iData's report, U.S. Market for Urological Devices 2010, states that the combined prostate cancer treatment market, including surgical...

2009-04-24 14:57:00

Company will showcase technologies for brachytherapy, intensity-modulated radiotherapy (IMRT), RapidArc(TM) radiotherapy, and stereotactic body radiotherapy (SBRT) PALO ALTO, Calif., April 24 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) will showcase the company's full spectrum of prostate cancer treatment technologies at the upcoming American Urological Association (AUA) Meeting at McCormick Place in Chicago from April 25-30. "Varian offers state-of-the-art technology for...

2008-07-10 12:01:17

Theragenics Corporation, a medical device Company serving the prostate cancer and surgical markets (NYSE: TGX), is challenging men to engage in a national debate surrounding the treatment of the disease that will affect one in six of them - prostate cancer. This week, the Company announced its latest campaign to promote awareness of proven prostate cancer treatment options, "The Great Prostate Debate." The campaign encourages open dialogue among men through town-hall events in select cities,...

2008-07-09 18:00:35

CHARLOTTE, N.C., July 9 /PRNewswire/ -- USHIFU, LLC, a global leader in non invasive high intensity focused ultrasound (HIFU) technology, is proud to announce sponsorship of the Sonablate(R) International HIFU Registry (SIHR), along with co-sponsors Misonix, Inc. and Takai Hospital Supply Co., Ltd., (THS). The SIHR is the first and only worldwide registry to gather information about prostate cancer treatment using HIFU. It was established to offer a single, secure, standardized repository...

2006-08-08 14:27:54

NEW YORK (Reuters Health) - Many prostate cancer survivors who have sexual difficulties post-treatment have never tried erectile dysfunction therapies, such as Viagra, a new study shows. The likelihood that a man will seek treatment for erectile problems varies with the type of prostate cancer treatment he received, the researchers found. While past research has shown that only about half of prostate cancer survivors with erectile dysfunction seek treatment, there is little...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related